Latest News for: rtw

Edit

GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Bioscience

Pharmiweb 16 Dec 2025
(“GenSci”), RTW Investments, LP (“RTW”), and Yarrow Bioscience, Inc ... “This landmark partnership with RTW Investments and Yarrow Bioscience, Inc is a strategic step in our vision of becoming a global pharma innovator ... About RTW Investments, LP.
Edit

PERKESO Handled Over 1,000 RTW Cases Since 2024

Malaysian National News Agency 16 Nov 2025
PERKESO Handled Over 1,000 RTW Cases Since 2024 ... has handled 1,238 Return To Work (RTW) motivation cases since 2024.
Edit

Beneficial Ownership Report (Form SC 13G) (RTW Investments LP)

Public Technologies 14 Nov 2025
RTW Investments LP published this content on November 14, 2025, and is solely ...
Edit

Amendment to Beneficial Ownership Report (Form SC 13G/A) (RTW Investments LP)

Public Technologies 14 Nov 2025
RTW Investments LP published this content on November 14, 2025, and is solely ...
Edit

Initial Quarterly Holdings Report by Institutional Manager (Form 13F-HR) (RTW Investments LP)

Public Technologies 14 Nov 2025
) ... The reader should not assume that the information is accurate and complete ... Washington, D.C. 20549 ... RTW INVESTMENTS, LP ... 0 ... RTW Investments LP published this content on November 14, 2025, and is solely responsible for the information contained herein.
Edit

Amendment to Beneficial Ownership Report (Form SC 13D/A) (RTW Investments LP)

Public Technologies 13 Nov 2025
RTW Investments LP published this content on November 13, 2025, and is solely ...
Edit

Savara announces $75M Royalty Funding Agreement with RTW to Support the Potential Launch of MOLBREEVIx ...

Business Wire 30 Oct 2025
... agreement with funds managed by RTW Investments, LP (RTW), subject to FDA approval of MOLBREEVI.
Edit

SAVARA ANNOUNCES $75M ROYALTY FUNDING AGREEMENT WITH RTW TO SUPPORT THE POTENTIAL LAUNCH OF MOLBREEVI* IN AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS (AUTOIMMUNE PAP) (Form 8-K) (Savara Inc)

Public Technologies 29 Oct 2025
SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced a $75 million royalty funding agreement with funds managed by RTW Investments, LP (RTW), subject to FDA approval of MOLBREEVI.
Edit

DWC posts draft regulations updating SJDB/RTW rules to online forum for public comment (California Department of Industrial Relations)

Public Technologies 20 Oct 2025
). NEWSLINE. The Division of Workers' Compensation (DWC) has posted proposed changes to its Supplemental Job Displacement Benefits (SJDB) rules and forms on its online forum page where members of the public may review and comment on the proposals.
Edit

RTW Investments' Rod Wong: Expect more deals in biotech space

CNBC 10 Oct 2025
Rod Wong, RTW Investments CIO & Managing Director, joins CNBC's 'Money Movers' to discuss J&J's reported interest in buying Protagonist Therapeutics, whether he expects more consolidation in the sector, and much more ... .
  • 1
×